Fairmount Funds Management as of March 31, 2020
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 14 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 15.5 | $26M | 604k | 42.25 | |
| Zogenix | 14.6 | $24M | 972k | 24.73 | |
| Insmed (INSM) | 9.9 | $16M | 1.0M | 16.03 | |
| Iovance Biotherapeutics (IOVA) | 8.9 | $15M | 491k | 29.94 | |
| Amicus Therapeutics (FOLD) | 7.5 | $12M | 1.3M | 9.24 | |
| Axsome Therapeutics (AXSM) | 6.8 | $11M | 190k | 58.83 | |
| Karyopharm Therapeutics (KPTI) | 6.6 | $11M | 562k | 19.21 | |
| Argenx Se (ARGX) | 6.1 | $10M | 77k | 131.74 | |
| Neoleukin Therapeutics | 5.6 | $9.2M | 810k | 11.38 | |
| Enanta Pharmaceuticals (ENTA) | 5.3 | $8.7M | 170k | 51.43 | |
| Allakos (ALLK) | 4.8 | $7.9M | 179k | 44.49 | |
| Trillium Therapeutics, Inc. Cmn | 4.5 | $7.3M | 1.8M | 4.04 | |
| Amarin Corporation (AMRN) | 2.1 | $3.5M | 872k | 4.00 | |
| Kiniksa Pharmaceuticals | 1.9 | $3.1M | 200k | 15.48 |
